<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Drew Endy on Engineering Biology</title>
	<atom:link href="http://biotec.molecularpharming.org/2008/02/23/drew-endy-on-engineering-biology/feed/" rel="self" type="application/rss+xml" />
	<link>http://biotec.molecularpharming.org/2008/02/23/drew-endy-on-engineering-biology/</link>
	<description>University of Northern Iowa</description>
	<pubDate>Thu, 08 Jan 2009 13:03:37 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
		<item>
		<title>By: Biotechnology &#187; Blog Archive &#187; Biotechnology Business: Study results from Robert Koch Institute ...</title>
		<link>http://biotec.molecularpharming.org/2008/02/23/drew-endy-on-engineering-biology/#comment-285</link>
		<dc:creator>Biotechnology &#187; Blog Archive &#187; Biotechnology Business: Study results from Robert Koch Institute ...</dc:creator>
		<pubDate>Mon, 25 Feb 2008 15:09:58 +0000</pubDate>
		<guid isPermaLink="false">http://biotec.molecularpharming.org/2008/02/23/drew-endy-on-engineering-biology/#comment-285</guid>
		<description>[...] Drew Endy on Engineering BiologyThis one is a talk with Drew Endy, a bioengineer at MIT. Despite existing for 30 years, we still haven’t realized much of the promise of biotechnology and Endy believes this is because we haven’t invested enough in making [&#8230;] [...]</description>
		<content:encoded><![CDATA[<p>[...] Drew Endy on Engineering BiologyThis one is a talk with Drew Endy, a bioengineer at MIT. Despite existing for 30 years, we still haven’t realized much of the promise of biotechnology and Endy believes this is because we haven’t invested enough in making [&#8230;] [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
